Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Verve Therapeutics Inc (NASDAQ: VERV) closed at $4.98 up 2.05% from its previous closing price of $4.88. In other words, the price has increased by $2.05 from its previous closing price. On the day, 1.41 million shares were traded. VERV stock price reached its highest trading level at $5.05 during the session, while it also had its lowest trading level at $4.755.
Ratios:
For a deeper understanding of Verve Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 19.82 and its Current Ratio is at 19.82. In the meantime, Its Debt-to-Equity ratio is 0.13 whereas as Long-Term Debt/Eq ratio is at 0.11.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on April 08, 2024, initiated with a Buy rating and assigned the stock a target price of $15.
On April 13, 2023, Canaccord Genuity started tracking the stock assigning a Buy rating and target price of $29.
On February 01, 2023, Cantor Fitzgerald started tracking the stock assigning a Neutral rating and target price of $21.Cantor Fitzgerald initiated its Neutral rating on February 01, 2023, with a $21 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on May 14 ’24 when Ashe Andrew D. bought 76,000 shares for $6.26 per share. The transaction valued at 475,760 led to the insider holds 342,509 shares of the business.
Nickerson Joan sold 1,514 shares of VERV for $12,475 on Apr 02 ’24. The Chief Administrative Officer now owns 8,659 shares after completing the transaction at $8.24 per share. On Nov 29 ’23, another insider, Dorval Allison, who serves as the Chief Financial Officer of the company, sold 554 shares for $11.45 each. As a result, the insider received 6,343 and left with 4,060 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VERV now has a Market Capitalization of 418148224 and an Enterprise Value of -114544848. For the stock, the TTM Price-to-Sale (P/S) ratio is 26.05 while its Price-to-Book (P/B) ratio in mrq is 0.72. Its current Enterprise Value per Revenue stands at -7.137 whereas that against EBITDA is 0.531.
Stock Price History:
Over the past 52 weeks, VERV has reached a high of $21.04, while it has fallen to a 52-week low of $4.59. The 50-Day Moving Average of the stock is -13.22%, while the 200-Day Moving Average is calculated to be -53.69%.
Shares Statistics:
For the past three months, VERV has traded an average of 1.52M shares per day and 1788990 over the past ten days. A total of 81.97M shares are outstanding, with a floating share count of 63.94M. Insiders hold about 23.85% of the company’s shares, while institutions hold 81.68% stake in the company. Shares short for VERV as of 1718323200 were 17643596 with a Short Ratio of 11.59, compared to 1715731200 on 17591233. Therefore, it implies a Short% of Shares Outstanding of 17643596 and a Short% of Float of 25.129997999999997.
Earnings Estimates
Its stock is currently analyzed by 10.0 different market analysts. On average, analysts expect EPS of -$0.68 for the current quarter, with a high estimate of -$0.58 and a low estimate of -$0.77, while EPS last year was -$0.87. The consensus estimate for the next quarter is -$0.71, with high estimates of -$0.63 and low estimates of -$0.81.
Analysts are recommending an EPS of between -$2.38 and -$3.04 for the fiscal current year, implying an average EPS of -$2.69. EPS for the following year is -$2.92, with 10.0 analysts recommending between -$2.25 and -$3.59.
Revenue Estimates
A total of 11 analysts have provided revenue estimates for VERV’s current fiscal year. The highest revenue estimate was $44.7M, while the lowest revenue estimate was $5.69M, resulting in an average revenue estimate of $15.28M. In the same quarter a year ago, actual revenue was $11.76M
